Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 3/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.41 |
| ▸ | AHR | P35869 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17944000 | 0.98 | CYP1A1 (0.43) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL17943900 | 0.97 | CYP1A1 (0.41) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL10122698 | 0.97 | CYP1A1 (0.41) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL10122704 | 0.97 | CYP1A1 (0.41) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL20127338 | 0.97 | CYP1A1 (0.41) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL20127390 | 0.97 | CYP1A1 (0.40) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL17931917 | 0.96 | ABCG2 (0.42) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL17944046 | 0.96 | ABCG2 (0.42) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL17944027 | 0.94 | ABCG2 (0.46) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 | |
| SCHEMBL17931971 | 0.94 | ABCG2 (0.46) | CYP1A1CYP1B1TDP1L3MBTL1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RER1, NR0B1, NR2E1 | CYP1A1 399/4885CYP1B1 341/4885TDP1 3427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.